首页|药学服务在慢性阻塞性肺疾病患者慢病管理中的应用效果

药学服务在慢性阻塞性肺疾病患者慢病管理中的应用效果

扫码查看
目的 探讨药学服务在慢性阻塞性肺疾病患者慢病管理中的应用效果.方法 选取2022年3月至2023年2月中山大学附属第三医院粤东医院收治的慢性阻塞性肺疾病患者100例,采用随机数字表法分为对照组和实验组,对照组按常规诊疗,实验组在对照组基础上提供全过程的药学服务干预.6个月后对比两组患者的用药依从性、急性加重次数、生活质量.结果 干预前,患者的Morisky用药依从性评分、急性加重导致住院≥1次的患者例数、慢性阻塞性肺疾病评估测试(CAT)和改良的呼吸困难量表(mMRC)比较,两组间的差异均无统计学意义(P>0.05).干预后实验组患者Morisky用药依从性评分好于对照组(P<0.05);干预后因急性加重导致住院≥1次的患者例数,实验组明显低于对照组(P<0.05);干预后实验组的CAT评分和mMRC评分均低于对照组(P<0.05).结论 药学服务可有效提高慢性阻塞性肺疾病患者的用药依从性、减少急性发作次数,改善生活质量.
Application Effect of Pharmaceutical Care in Chronic Disease Manage-ment of Patients with Chronic Obstructive Pulmonary Disease
OBJECTIVE To explore the application effect of pharmaceutical care in chronic disease managing disease in individuals with chronic obstructive pulmonary disease.METHODS A total of 100 patients with chronic obstructive pulmonary disease treated in the Third Affiliated Hospital of Sun Yat-Sen University Yuedong Hospital from March 2022 to February 2023 were selected and divided into control group and experimental group by random number table method.The control group was treated according to routine treatment,and the experimental group was provided with pharmaceutical care intervention throughout the whole process on the basis of the control group.After 6 months,the medication compliance,the number of acute exacerbations and the quality of life of the two groups were compared.RESULTS Before intervention,there was no significant difference in Morisky medication compliance score,number of patients hospitalized for ≥ 1 time due to acute exacerbation,chronic obstructive pulmonary disease assessment test(CAT)and modified dyspnea Scale(mMRC)between 2 groups(P>0.05).Morisky medication compliance score of the experimental group was better than that of the control group after intervention(P<0.05).The number of patients hospitalized for≥1 time due to acute aggravation aftes intervention was significantly lower in the experimental group than in the control group(P<0.05).After intervention,the CAT score and mMRC score of the experimental group were lower than those of the control groupt(P<0.05).CONCLUSION Pharmaceutical serv-ices can effectively improve medication compliance,reduce the frequency of acute attacks,and improve the quality of life for patients with chronic obstructive pulmonary disease.

Pharmaceutical careChronic obstructive pulmonary diseaseMedication complianceThe number of acute exacerba-tionsQuality of life

肖勇泰、黄程、丘志光

展开 >

中山大学附属第三医院粤东医院药剂科,广东梅州 514700

药学服务 慢性阻塞性肺疾病 用药依从性 急性加重次数 生活质量

2024

海峡药学
中国药学会福建分会

海峡药学

影响因子:0.643
ISSN:1006-3765
年,卷(期):2024.36(11)